Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - STOCK-BASED COMPENSATION
Stock-based Compensation IOVA - Iovance Biotherapeutics, Inc.
62.6 M
LAST VALUE
-5.26%
2 YEAR CAGR
25.61%
5 YEAR CAGR
12.27%
10 YEAR CAGR